Pain specialist Steven King, MD, highlights a new review that looks at the complex, bidirectional relationship between sleep disturbance and chronic pain.
To redefine the word "pain," the IASP invited ethicists and philosophers to assist in the process. A one-time IASP taxonomy task force member highlights the process.
SAMPLE: Based on current research, what is the prevalence of fibromyalgia in the general population? Plus 11 more questions on fibromyalgia and chronic pain.
The new joint guideline recommends topical NSAIDs as first-line therapy for treating acute pain from non-low back musculoskeletal injuries in adults.
All makers of opioid and opioid use disorder medications must revise labels to recommend discussion and coprescribing of naloxone.
Results of a new study show yoga and physical therapy can be beneficial treatment options for adults with chronic low back pain.
Galt Pharmaceuticals announced FDA approval of Orphengesic Forte (orphenadrine citrate, aspirin, caffeine), to treat acute mild to moderate pain.
The AHRQ evaluates nonopioid medications including NSAIDs, gabapentinoids, antidepressants, and cannabinoids for efficacy in treatment of chronic noncancer pain.
The FDA recently approved an implantable neurostimulation system for the treatment of chronic low back pain.
Incident cardiovascular disease is significantly increased among women with migraine with aura vs migraineurs without aura and those who do not have migraine.